VPValentina D. Petrova

Valentina D. Petrova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Valentina D. Petrova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Analysis of Thyroid Cancer Incidence Trends in Altai Krai Focusing on the Impact of Papillary Microcarcinomas on Morbidity Structure

    by Irina M. Zakharova, Alexander F. Lazarev, Valentina D. Petrova, Dmitry I. Ganov, Svetlana A. Terekhova, Nina V. Trukhacheva, Julia A. Antonova, Elizaveta K. Semeryanova

    BACKGROUND: In recent years, the incidence of thyroid cancer has been increasing, primarily due to the rising detection of papillary microcarcinomas (T1a). However, the mortality rates have not declined. This study is devoted to evaluate trends in thyroid cancer incidence in Altai Krai, with a particular focus on the T1a subcategory. AIM: The work aimed to study the trends of thyroid cancer incidence in Altai Krai in 2014–2023, with a focus on tumors at the papillary microcarcinoma stage (T1a), including their recurrence rates. METHODS: Data from the regional cancer registry were used. Incidence rates, stage distribution, histological structure, and recurrence rates were assesed. The data were than compared to those from across Russia, along with the international data on active observation. RESULTS: The incidence rate in the region was 3–4 times higher than the average rate in Russia. Stage T1 accounted for 66.4% of cases, with T1a representing 36.1%. The recurrence rate of papillary microcarcinomas remained below 4%, with a declining trend reaching 0.35% in 2023. CONCLUSION: The high proportion of early-stage tumors and the low recurrence rate of papillary microcarcinomas highlight the potential for incorporating active surveillance strategies into Russian clinical practice.


  • Open Access

    Possible risk factors for thyroid cancer (on the example of Altai Territory residents)

    by I. M. Zakharova, A. F. Lazarev, V. D. Petrova, D. I. Ganov, S. A. Terekhova, N. V. Trukhacheva, Yu. A. Antonova

    Purpose of the study. To study the prognostic significance of various exogenous and endogenous risk factors for thyroid cancer (TC). Materials and methods. The influence of various exogenous and endogenous factors, as well as anamnestic data, as indirect predictors of the development of TC, was studied in 1463 patients: in the main group, which included 505 patients with a verified diagnosis of TC and a control group formed by a continuous method, 958 people were free from MNs. Statistical data processing was performed using Orange Data Mining software (3–3.37.0) and RStudio (version 4.3.1). The character of the distribution of quantitative variables was assessed using the Kolmogorov–Smirnov and Shapiro–Wilk criteria. When using the Kolmogorov–Smirnov criterion, the hypothesis of the normality of the distribution is rejected at p < 0.20, when using the Shapiro–Wilk criterion – at p < 0.05. Results. A comparative analysis showed a statistically significant association of a number of factors with the development of TC: female sex and age over 51 years, an overwhelming hereditary history, occupational hazards, mental work, surgery and chronic thyroid diseases, impaired homeostasis, and others, a total of 28 factors (p < 0.001). Factors preventing the development of TC were identified: male gender and age 45 years and younger, physical labor, melancholic temperament, sleep duration of more than 7 hours (p < 0.001). Factors such as smoking, alcohol intake, and iodized salt did not have a statistically significant effect when comparing the studied groups in the Altai Territory. Conclusion. The conducted research allowed us to identify significant factors contributing to and hindering the development of TC. It has been established that none of the risk factors has an independent decisive significance, and therefore it is necessary to calculate the total risk according to the original formula, which will determine the personalized risk of developing TC and targeted prevention measures.


  • Open Access

    Microbiome and Human Cancer: Descriptive Literature Review

    by Diana N. Arutyunyan, Valentina D. Petrova, Svetlana A. Terekhova, Alexander F. Lazarev

    The term “microbiome” is defined as the community of all microorganisms and their metabolic byproducts within their environment. It also refers to the complete set of genetic material and the relationships between these microorganisms within a specific ecological setting throughout a certain period of time. The human microbiome profile develops from birth and remains relatively stable throughout adult life. The microbiota’s primary functions include involvement in the most essential processes of the body’s vital activity, such as the development of adaptive mechanisms, immune defense, physiological homeostasis, cognitive function, and regulation of energy resources within the body. Consequently, the microbiota plays a pivotal role in preserving equilibrium within the macroorganism itself and between the macroorganism and its environment. This article presents the findings of numerous scientific investigations that examine the impact of microbiota on the vital activity of tumors. These studies demonstrate that the microbiota can either accelerate or decelerate tumor growth, and in certain instances, the bacterial community does not contribute to the development of tumors. Tumors, characterized by the profound cellular changes resulting from the impairment of essential DNA mechanisms, create a specific environment that fosters bacterial colonization. In general, tumor tissue is known to have a higher bacterial load compared to normal tissue. Bacteria have been observed to produce certain metabolites that are subsequently used by tumor cells. Consequently, these bacteria and tumor cells compete directly for nutrients essential to their vital functions. The study examines the conditions underlying a particular scenario in which tumors and microbiota may interact. The review presents findings from studies that have sought to regulate intratumor microbes as a potential new target for anti-cancer therapy. This includes the use of bacterial platforms and fecal microbiota transplantation. Additionally, this study presents investigational findings concerning the use of microbiota in the treatment of acute respiratory viral infection, with a focus on chemotherapeutic and immunotherapeutic protocols. These findings corroborate the efficacy of microbiota-based interventions and concurrently highlight the potential for adverse complications.

  • Targeted diagnostics of breast cancer based on a comprehensive analysis of risk factors

    by Alexander F. Lazarev, Valentina D. Petrova, Sergey A. Lazarev, Zhanna I. Vakhlova, Maria G. Nikolaeva, Tatyana V. Repkina, Svetlana A. Terekhova, Ilya S. Osipov, Evgenia V. Shlyaptseva, Anna N. Komarova, et al.

    BACKGROUND: To date, there are no effective methods for early diagnosis and screening of breast cancer. High-tech methods, such as magnetic resonance imaging and contrasted computed tomography, as well as positron emission computed tomography have high resolution, but their high cost does not allow the use of these techniques for screening and primary diagnosis. AIM: To improve the quality and efficiency of diagnostic measures for breast cancer through a personalized approach based on an analysis of a set of risk factors. MATERIALS AND METHODS: Data from the population cancer registry of the Altai Territory, created at the Altai Regional Oncology Center (Barnaul, Russia), were used. To date, the register includes information on 308 550 patients with malignant neoplasms, including 31 783 women with breast cancer. Based on the method of targeted prevention by A.F. Lazarev “Method for determining the risk of breast cancer according to Lazarev A.F.” (Patent No. 2651131) an “Automated program for early diagnosis of breast cancer” was developed. The program significantly reduces the time for the formation of groups of high cancer risk precancers and increases the efficiency of breast cancer detection, and also makes it possible to develop a set of targeted preventive measures personally for each patient. Testing of this algorithm included testing of 512 patients, as a result of which a high-risk precancer group was formed. In the established register, patients underwent a complex of in-depth examinations (ultrasound examination, mammography, magnetic resonance imaging with dynamic contrast, and puncture of tumors if indicated). RESULTS: The precancer group at high risk of developing breast cancer consisted of 92 patients, in-depth examination revealed 7 patients with established breast cancer, which amounted to 7.6%. All cases of breast cancer were detected in stages I and II. CONCLUSION: Targeted diagnostics using the “Automated program for early diagnosis of breast cancer” allows to improve the quality and efficiency of diagnostic measures for breast cancer identification through personalized approach, using multiple risk factors.

  • Early diagnostics of prostate cancer based on a comprehensive analysis of risk factors

    by Alexander F. Lazarev, Valentina D. Petrova, Sergey A. Lazarev, Tatiana V. Repkina, Svetlana A. Terekhova, Pavel A. Obеremok, Ilya S. Osipov, Maria G. Nikolaeva, Dmitriy I. Ganov

    BACKGROUND: There is a trend of increasing incidence and mortality from prostate cancer. Existing methods for early diagnosis and screening of prostate cancer did not demonstrate enough efficiency. AIM: To improve the quality and efficiency of diagnostic measures for prostate cancer through a personalized approach to patients based on an analysis of a set of risk factors. MATERIALS AND METHODS: The methodology was developed using the data from the population-based Cancer Registry of the Altai Territory, created at the Altai Regional Oncology Center in Barnaul, Russia. At the moment the Cancer Registry included information on 308 550 patients with malignant neoplasms, including 15 167 males with prostate cancer. On the basis of the method of prostate cancer risk assessment proposed by Lazarev AF an automated program for early diagnosis of prostate cancer has been developed. Testing of this technique included assessment of 532 patients (aged between 23 and 82). RESULTS: 128 patients were determined to belong to the high risk pre-cancer group. A high-risk precancer registry was created, which included the patients having individual risk of developing prostate cancer either increased or high or absolute. Upon a set of in-depth examinations, 7 of 128 patients (9.3%) were diagnosed with prostate cancer, all at early stages (I or II). Thus, the incidence of prostate cancer among the patients from the high risk pre-cancer registry was significantly higher than the average observed during prophylactic examinations (0.01%). CONCLUSION: The automated program for early diagnosis of prostate cancer could be implemented with the aim to assign in-depth examination in more targeted manner to patients at high risk of prostate cancer and to contribute to detection the cancer in the early stages.

  • Risk factors for thyroid cancer

    by Aleksandr F. Lazarev, Irina M. Zayarova, Valentina D. Petrova

    Thyroid cancer (TC) is the most common tumor among endocrine malignant neoplasms all over the world. Over the past 20 years, there has been not only an increase in the indicators of true morbidity (not associated with active detection) of TC, but also the absence of a decrease in mortality and disability in this pathology. The identification of causal factors is important for clinical and scientific purposes, as it is the main requirement for the development of preventive measures and early diagnosis, forecasting the dynamics of the incidence of TC. The article provides an overview of known risk factors for the development of TC using sources of foreign and domestic literature, where preference is given to the results of large-scale scientific research. The article presents a wide range of causes of the development of TC: ionizing radiation, genetic factors, dietary characteristics, background diseases, and others.


  • Digital technologies in prostate cancer prevention and early diagnosis

    by A. F. Lazarev, Valentina D. Petrova, V. P. Pokornyak, S. A. Lazarev, V. A. Marchkov, D. I. Ganov

    Background. Prostate cancer is one of the most common malignant neoplasms in males. The Russian Federation observed the same patterns: the incidence of prostate cancer is steadily growing, without the tendency to decrease. Currently, no effective methods are available for prostate cancer early diagnosis and screening. Aim. To improve the effectiveness of prostate cancer prevention and early diagnosis with new digital technologies for high-risk cancer group formation Material and methods. Data from the Cancer Registry population in the Altai regional cancer center, Barnaul City was used. The Cancer Registry includes information about 253,000 patients with malignant neoplasms, including 14,482 males suffering from prostate cancer. Based on the targeted prevention method of A.F. Lazarev, Method for determining the risk of prostate cancer (Patent 2692987) and Automated program for early diagnosis of prostate cancer (certificate of state registration of the computer program No. 2019663514) was developed, which simplifies the stage of forming groups of precancerous high oncorisk and increases prostate cancer detection, as well as develops personalized targeted preventive measures for each patient. Results. The study formed a group of 328 patients with precancerous high oncorisk for prostate cancer in the Cancer Registry, wherein an in-depth examination revealed 26 patients with prostate cancer, which was 7.9%. Stages I and II were established in 97.8%. Conclusion. The web application Automated program for early diagnosis of prostate cancer allows the group formation of high-risk patients who are a targeted search for prostate cancer. The testing process allows a large number of patients to be examined in a short time. The automated program for the early diagnosis of prostate cancer allows a statistically significant increased prostate cancer detection, as well as personalized preventive measure suggestions for each patient.

  • Open Access

    Prevention of post-radiation damage to the bladder with medicinal plants in patients with locally advanced forms of cervical cancer

    by S. V. Korepanov, A. F. Lazarev, M. G. Nikolaeva, V. D. Petrova

    Objective: to study the effect of phytotherapy on the frequency and extent of post-radiation injuries in patients with locally advanced forms of cervical cancer who received chemo-radiation treatment. Material and methods: a randomized clinical trial was conducted, including 2 groups of patients aged 2464 years with a morphologically confirmed diagnosis of locally advanced (IIbIIIb) cervical cancer. The main group consisted of 350 patients who received standard chemo-radiation therapy against the background of therapy with medicinal plants using the original patented method, and a comparison group of 402 patients who received only standard special treatment. Results: accompanying therapy with medicinal plants reduces the risk of early post-radiation complications of the bladder (erosive cystitis) in patients of the main group by 1.4 times [2.9 (3.72.1) % vs. 4.0 (5.03.0)% ; p = 0.0001]; late (5 years after treatment) 2.9 times [0.9 (0.960.84) % vs. 2.6 (3.71.5) %; p = 0.0001].

  • Open Access

    Possibilities of medicinal plants in accompanying therapy and rehabilitation of patients with malignant neoplasms of the cervix

    by S. V. Korepanov, A. F. Lazarev, M. G. Nikolaeva, V. D. Petrova

    The review of references shows the influence of accompanying therapy based on drugs from medicinal plants on the dynamics of various indicators of homeostasis in patients with locally advanced cervical cancer.

  • Algorithm of monitoring of patients with family history of cancer as a method of cancer prevention

    by V. D. Petrova, T. V. Sinkina, N. A. Zarubina, S. A. Terekhova, J. N. Dimitriadi, I. A. Selezneva, A. F. Lazarev

    1542 Background: Existent genetic tests are not able to provide effective forecasting of all cancer sites and all those methods are generally expensive. At the same time approximately 50% of population has cancer susceptibility and 10% - hereditary cancer syndromes. The purpose of this study was to develop the algorithm of monitoring to provide effective forecasting and prevention of cancer in patients with hereditary cancer susceptibility. Methods: The algorithm of monitoring of patients with family history of cancer includes 2 stage: I - diagnostic, II - treatment and rehabilitation. In the I stage patients with 3 and more relatives by blood who had cancers of any site are revealed by oncologist. Their genealogical trees are analyzed by geneticist. All those patients are registered in the registry of “cancer”-families’ members, interviewed and got all the necessary diagnostic procedures with the following multivariative analysis (of more than 200 geno- and phenotypic characteristics). Patients with determined high risk of malignancies undergo deep clinical and instrumental examination, site-by-site searching for cancer, molecular genetic tests. In the II stage individual recommendations for the patients are developed, pretumour lesions are treated, preventative surgery is performed (resection of a target organ) and the measures for strengthening of anti-tumour resistance are taken. All the patients of the registry get the periodic health examination for term of life: preventive examination once per 6 months, multivariative analysis once per 3 years. Results: The registry of “cancer”-families’ members included 421 families - 1833 patients (232 men and 1601 women at the age of 28–74). In 2003–2006 there were revealed obligatory pre-cancer lesions in 637 patients, cancers in situ - in 45 patients, and cancers of different sites - in 69 patients (in I stage - 78.3%, II stage - 18.9%, III stage - 2.8%, IV stage - 0). Conclusions: This algorithm of monitoring of the patients from the registry of “cancer”-families’ members made it possible to provide high effectiveness of cancer prevention and early detection. No significant financial relationships to disclose.